Cdk5-dependent regulation of glucose-stimulated insulin secretion
The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
Tight glycemic control in individuals with diabetes mellitus is essential to prevent or delay its complications. Present treatments to reduce hyperglycemia mainly target the ATP-sensitive K(+) (K(ATP)) channel of pancreatic beta cells to increase insulin secretion. These current approaches are often associated with the side effect of hypoglycemia. Here we show that inhibition of the activity of cyclin-dependent kinase 5 (Cdk5) enhanced insulin secretion under conditions of stimulation by high glucose but not low glucose in MIN6 cells and pancreatic islets. The role of Cdk5 in regulation of insulin secretion was confirmed in pancreatic beta cells deficient in p35, an activator of Cdk5. p35-knockout mice also showed enhanced insulin secretion in response to a glucose challenge. Cdk5 kinase inhibition enhanced the inward whole-cell Ca(2+) channel current and increased Ca(2+) influx across the L-type voltage-dependent Ca(2+) channel (L-VDCC) upon stimulation with high glucose in beta cells, but had no effect on Ca(2+) influx without glucose stimulation. The inhibitory regulation by Cdk5 on the L-VDCC was attributed to the phosphorylation of loop II-III of the alpha(1C) subunit of L-VDCC at Ser783, which prevented the binding to SNARE proteins and subsequently resulted in a decrease of the activity of L-VDCC. These results suggest that Cdk5/p35 may be a drug target for the regulation of glucose-stimulated insulin secretion.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CDK5 has been implicated in the regulation of pancreatic beta cell function, through formation of p35/CDK5 complexes that downregulate insulin expression (11, 12).”
From Replication of Genome-Wide Association Signals in UK Samples Reveals Risk Loci for Type 2 Diabetes (2007) · cites this paper as [12]
Citations
Cites
Reconstitution of I KATP : An Inward Rectifier Subunit Plus the Sulfonylurea Receptor
Inagaki, N., Gonoi, T., Clement, J. P., Namba, N., Inazawa, J., Gonzalez, G., Aguilar-Bryan, L., Seino, S., & Bryan, J. (1995) · Science · doi:10.1126/science.270.5239.1166 · Cited by 1,709
New drug targets for type 2 diabetes and the metabolic syndrome
Moller, D. E. (2001) · Nature · doi:10.1038/414821a · Cited by 1,008 · cited 1×
“dtd" [ ]> Tight glycemic control in individuals with diabetes mellitus is essential to prevent or delay its complication”
p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5
Tsai, L.-H., Delalle, I., Caviness, V. S., Chae, T., & Harlow, E. (1994) · Nature · doi:10.1038/371419a0 · Cited by 922
Chae, T., Kwon, Y. T., Bronson, R., Dikkes, P., Li, E., & Tsai, L.-H. (1997) · Neuron · doi:10.1016/s0896-6273(01)80044-1 · Cited by 715 · cited 1×
“We further investigated Ca 2+ influx in beta cells isolated from p35-knockout mice, in which Cdk5 kinase activity is extremely lo”
BackgroundInhibition of Cyclin‐Dependent Kinases by Purine Analogues
Veselý, J., Havliček, L., Strnad, M., Blow, J. J., Donella‐Deana, A., Pinna, L., Letham, D. S., Kato, J., Detivaud, L., Leclerc, S., et al. (1994) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1994.00771.x · Cited by 632
A brain-specific activator of cyclin-dependent kinase 5
Lew, J., Huang, Q.-Q., Qi, Z., Winkfein, R. J., Aebersold, R., Hunt, T., & Wang, J. H. (1994) · Nature · doi:10.1038/371423a0 · Cited by 579
cAMP-GEFII is a direct target of cAMP in regulated exocytosis
Ozaki, N., Shibasaki, T., Kashima, Y., Miki, T., Takahashi, K., Ueno, H., Sunaga, Y., Yano, H., Matsuura, Y., Iwanaga, T., et al. (2000) · Nature Cell Biology · doi:10.1038/35041046 · Cited by 481
Activity and expression pattern of cyclin-dependent kinase 5 in the embryonic mouse nervous system
Tsai, L.-H., Takahashi, T., Caviness, V. S., & Harlow, E. (1993) · Development · doi:10.1242/dev.119.4.1029 · Cited by 457
An Isoform of the Neuronal Cyclin-dependent Kinase 5 (Cdk5) Activator
Tang, D., Yeung, J., Lee, K.-Y., Matsushita, M., Matsui, H., Tomizawa, K., Hatase, O., & Wang, J. H. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.45.26897 · Cited by 340
Self-citationTriggering and Augmentation Mechanisms, Granule Pools, and Biphasic Insulin Secretion
Bratanova-Tochkova, T. K., Cheng, H., Daniel, S., Gunawardana, S., Liu, Y.-J., Mulvaney-Musa, J., Schermerhorn, T., Straub, S. G., Yajima, H., & Sharp, G. W. G. (2002) · Diabetes · doi:10.2337/diabetes.51.2007.s83 · Cited by 291 · cited 1×
“The biochemical mechanism of insulin secretion has been studied extensively with the aim of identifying target molecules for the treatment of diabete”
BackgroundFunctional interaction of syntaxin and SNAP-25 with voltage-sensitive L- and N-type Ca2+ channels.
Wiser, O., Bennett, M. K., & Atlas, D. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00785.x · Cited by 267
Impaired insulin secretion and glucose tolerance in β cell‐selective CaV1.2 Ca2+ channel null mice
Schulla, V., Renström, E., Feil, R., Feil, S., Franklin, I., Gjinovci, A., Jing, X., Laux, D., Lundquist, I., Magnuson, M. A., et al. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg389 · Cited by 234
Tomizawa, K., Ohta, J., Matsushita, M., Moriwaki, A., Li, S.-T., Takei, K., & Matsui, H. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-07-02590.2002 · Cited by 205 · cited 1×
“Cdk5 has been reported to phosphorylate the α 1C subunit of P/Q-type Ca 2+ channels in neurons, although no modification of the Ca 2+ channel current has previously been show”
BackgroundSelf-citationTomizawa, K., Sunada, S., Lu, Y.-F., Oda, Y., Kinuta, M., Ohshima, T., Saito, T., Wei, F.-Y., Matsushita, M., Li, S.-T., et al. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200308110 · Cited by 198 · cited 1×
“Purified recombinant proteins were phosphorylated by Cdk5 (Upstate) in vitro as described previousl”
MethodSelf-citationYokoyama, C. T., Sheng, Z.-H., & Catterall, W. A. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-18-06929.1997 · Cited by 149 · cited 1×
“A previous study also showed that synaptic protein interaction sites are localized in L II-III of VDCCs and the association is regulated by phosphorylatio”
BackgroundMinami, K., Yano, H., Miki, T., Nagashima, K., Wang, C.-Z., Tanaka, H., Miyazaki, J.-I., & Seino, S. (2000) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2000.279.4.e773 · Cited by 133
Self-citationDifferential Gene Expression in Well-Regulated and Dysregulated Pancreatic β-Cell (MIN6) Sublines
Lilla, V., Webb, G., Rickenbach, K., Maturana, A., Steiner, D. F., Halban, P. A., & Irminger, J.-C. (2003) · Endocrinology · doi:10.1210/en.2002-220916 · Cited by 129
Ohshima, T., Ogawa, M., Veeranna, Hirasawa, M., Longenecker, G., Ishiguro, K., Pant, H. C., Brady, R. O., Kulkarni, A. B., & Mikoshiba, K. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051628498 · Cited by 122 · cited 1×
“We further investigated Ca 2+ influx in beta cells isolated from p35-knockout mice, in which Cdk5 kinase activity is extremely lo”
BackgroundSelf-citationLilja, L., Johansson, J. U., Gromada, J., Mandic, S. A., Fried, G., Berggren, P., & Bark, C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312711200 · Cited by 81 · cited 1×
“Recent studies have shown that p35 and p39 are expressed in pancreatic beta cell”
BackgroundUbeda, M., Kemp, D. M., & Habener, J. F. (2004) · Endocrinology · doi:10.1210/en.2003-1522 · Cited by 80
(1990) · Methods in Enzymology · doi:10.1016/0076-6879(90)92071-k · Cited by 61
Kawaki, J., Nagashima, K., Tanaka, J., Miki, T., Miyazaki, M., Gonoi, T., Mitsuhashi, N., Nakajima, N., Iwanaga, T., Yano, H., et al. (1999) · Diabetes · doi:10.2337/diabetes.48.10.2001 · Cited by 57 · cited 1×
“We recorded the whole-cell VDCC currents in MIN6 cells and mouse pancreatic beta cells using 40 mM Ba 2+ containing bath solutio”
MethodSelf-citation
Cited by
A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants
Scott, L. J., Mohlke, K. L., Bonnycastle, L. L., Willer, C. J., Li, Y., Duren, W. L., Erdos, M. R., Stringham, H. M., Chines, P. S., Jackson, A. U., et al. (2007) · Science · doi:10.1126/science.1142382 · Cited by 2,753
Replication of Genome-Wide Association Signals in UK Samples Reveals Risk Loci for Type 2 Diabetes
Zeggini, E., Weedon, M. N., Lindgren, C. M., Frayling, T. M., Elliott, K. S., Lango, H., Timpson, N. J., Perry, J. R. B., Rayner, N. W., Freathy, R. M., et al. (2007) · Science · doi:10.1126/science.1142364 · Cited by 2,194
A variant in CDKAL1 influences insulin response and risk of type 2 diabetes
Steinthorsdottir, V., Thorleifsson, G., Reynisdottir, I., Benediktsson, R., Jonsdottir, T., Walters, G. B., Styrkarsdottir, U., Gretarsdottir, S., Emilsson, V., Ghosh, S., et al. (2007) · Nature Genetics · doi:10.1038/ng2043 · Cited by 1,072
“In pancreatic beta cells, CDK5 has been shown to have a role in the loss of beta cell function under glucotoxic condition”
BackgroundGenome–wide association studies provide new insights into type 2 diabetes aetiology
Frayling, T. M. (2007) · Nature Reviews Genetics · doi:10.1038/nrg2178 · Cited by 594
“CDK5 is implicated in reduced β-cell function, through the formation of p35–CDK5 complexes, which downregulate insulin expressio”
BackgroundVolkmar, M., Dedeurwaerder, S., Cunha, D. A., Ndlovu, M. N., Defrance, M., Deplus, R., Calonne, E., Volkmar, U., Igoillo‐Esteve, M., Naamane, N., et al. (2012) · The EMBO Journal · doi:10.1038/emboj.2011.503 · Cited by 420
“(Figure 2C) CDK5R1 acts as an activator of CDK5 (Ubeda et al , 2004) whose expression is regulated by glucose and which inhibits insulin secretion (Wei et al , 2005).”
Metadata
- Authors
- Wei, F.-Y., Nagashima, K., Ohshima, T., Saheki, Y., Lu, Y.-F., Matsushita, M., Yamada, Y., Mikoshiba, K., Seino, Y., Matsui, H., & Tomizawa, K.
- Affiliations
- Okayama University (JP)
- Kyoto University (JP)
- RIKEN Center for Brain Science (JP)
- Corresponding author
- Tomizawa, Kazuhito
- ORCID
- Venue
- Nature Medicine
- Published
- 2005-09-11
- Volume
- 11
- Issue
- 10
- Pages
- 1104-1108
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2016207732
- Cited by
- 199
- References
- 22
- Citations by year
- 2026: 1 · 2025: 7 · 2024: 2 · 2023: 9 · 2022: 8 · 2021: 13 · 2020: 6 · 2019: 8 · 2018: 5 · 2017: 15 · 2016: 8 · 2015: 8 · 2014: 12 · 2013: 5 · 2012: 17
- FWCI
- 10.82
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Keywords
- cyclin-dependent kinase 5, Cdk5/p35, glucose-stimulated insulin secretion, pancreatic beta cells, L-type voltage-dependent calcium channels, SNARE proteins, calcium influx, MIN6 cells, diabetes mellitus, hypoglycemia
- MeSH terms
- Insulin Secretion, Animals, Cell Line, Glucose, Insulin, Kinetin, Nerve Tissue Proteins, Signal Transduction, Insulin-Secreting Cells, Cyclin-Dependent Kinase 5, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.